Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ginger D Constantine

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Drug Delivery and Translational Research|May 9, 2019
Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheepHerman Weiss, Bridget Martell, Ginger D Constantine, et al.
Menopause (New York, N.Y.)|December 7, 2016
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophyGinger D Constantine, James A Simon, James H Pickar, et al.
Obstetrics and Gynecology|June 12, 2018
A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled TrialRogerio A Lobo, David F Archer, Risa Kagan, et al.
Contraception|November 10, 2011
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderUriel Halbreich, Ellen W Freeman, Andrea J Rapkin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.
Contraception|November 17, 2009
Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trialAlexander Teichmann, Dan Apter, Janusz Emerich, et al.
Journal of Bone and Mineral Metabolism|April 10, 2014
Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosisAkira Itabashi, Kousei Yoh, Arkadi A Chines, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2010
Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosisAkira Itabashi, Kousei Yoh, Arkadi A Chines, et al.
BMC Musculoskeletal Disorders|June 24, 2010
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosisClaus Christiansen, Charles H Chesnut, Jonathan D Adachi, et al.
Menopause (New York, N.Y.)|June 23, 2009
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal womenDavid F Archer, JoAnn V Pinkerton, Wulf H Utian, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Drug Delivery and Translational Research|May 9, 2019
Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheepHerman Weiss, Bridget Martell, Ginger D Constantine, et al.
Menopause (New York, N.Y.)|December 7, 2016
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophyGinger D Constantine, James A Simon, James H Pickar, et al.
Obstetrics and Gynecology|June 12, 2018
A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled TrialRogerio A Lobo, David F Archer, Risa Kagan, et al.
Contraception|November 10, 2011
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderUriel Halbreich, Ellen W Freeman, Andrea J Rapkin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.
Contraception|November 17, 2009
Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trialAlexander Teichmann, Dan Apter, Janusz Emerich, et al.
Journal of Bone and Mineral Metabolism|April 10, 2014
Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosisAkira Itabashi, Kousei Yoh, Arkadi A Chines, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2010
Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosisAkira Itabashi, Kousei Yoh, Arkadi A Chines, et al.
BMC Musculoskeletal Disorders|June 24, 2010
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosisClaus Christiansen, Charles H Chesnut, Jonathan D Adachi, et al.
Menopause (New York, N.Y.)|June 23, 2009
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal womenDavid F Archer, JoAnn V Pinkerton, Wulf H Utian, et al.
Pageof 5